SoftOx Solutions AS, held its annual general meeting on 12 May 2022 at 12:00
hours (CEST).

All proposals were resolved as presented in the notice convening the annual
general meeting dated 5 May 2022, as further set out in the minutes from the
general meeting attached hereto.

For further information, please contact:
Geir Almås, CEO of SoftOx Solutions AS, or
Kristine Rød, CFO of SoftOx Solutions AS
Mail: ir@soft-ox.com
Phone: Front Desk: (+47) 948-59-599

About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian
biotech/medtech company based in Oslo with the aim of helping to combat major
threats to human health, namely the emergence of antimicrobial resistance (AMR),
biofilm infections in chronic wounds and the spread of viruses. For more
information on SoftOx, visit www.soft-ox.com.

This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.

Click here for more information

© Oslo Bors ASA, source Oslo Stock Exchange